Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
This article has been cited by
1Three Weekly Versus Weekly Cisplatin as Radiosensitizer in Head and Neck Cancer: a Decision Dilemma
Preety Negi,Pamela Alice Kingsley,Himanshu Srivastava,Surender Kumar Sharma
Asian Pacific Journal of Cancer Prevention.2016;17(4)1617
[DOI]
2A comparison of weekly versus 3-weekly cisplatin during adjuvant radiotherapy for high-risk head and neck cancer
Sjoukje F. Oosting,Tom W.W. Chen,Shao H. Huang,Lisa Wang,John Waldron,Ralph Gilbert,David Goldstein,Gyorgy B. Halmos,Max J.H. Witjes,Jourik A. Gietema,Brian O’Sullivan,Johannes A. Langendijk,Lillian L. Siu,Aaron R. Hansen
Oral Oncology.2016;59(4)43
[DOI]
3Comparison of weekly versus triweekly cisplatin delivered concurrently with radiation therapy in patients with locally advanced nasopharyngeal cancer: A multicenter randomized phase II trial (KCSG-HN10-02)
Ji Yun Lee,Jong-Mu Sun,Dong Ryul Oh,Sung Hee Lim,Juna Goo,Se-Hoon Lee,Sung-Bae Kim,Keon Uk Park,Hoon-Kyo Kim,Dae Sik Hong,Jun Suk Kim,Seong-Geun Kim,Seong Yoon Yi,Hwan Jung Yun,Myung Soo Hyun,Hyo Jung Kim,Sin-Ho Jung,Keunchil Park,Yong Chan Ahn,Myung-Ju Ahn
Radiotherapy and Oncology.2016;118(2)244
[DOI]
4Weekly Low-Dose Versus Three-Weekly High-Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non-Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta-Analysis of Aggregate Data
Petr Szturz,Kristien Wouters,Naomi Kiyota,Makoto Tahara,Kumar Prabhash,Vanita Noronha,Ana Castro,Lisa Licitra,David Adelstein,Jan B. Vermorken
The Oncologist.2017;22(9)1056
[DOI]
5Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study
Peter Mu-Hsin Chang,Po-Min Chen,Pen-Yuan Chu,Ling-Wei Wang,Shyh-Kuan Tai,Tung-Lung Tsai,Jui-Lin Huang,Yi-Fen Wang,Shyue-Yih Chang,Muh-Hwa Yang
Cancer Chemotherapy and Pharmacology.2008;63(1)9
[DOI]
6Toxicity of daily low dose cisplatin in radiochemotherapy for locally advanced head and neck cancer
Hendrik Andreas Wolff,Tobias Overbeck,Ralph M. Roedel,Robert M. Hermann,Markus K. A. Herrmann,Tereza Kertesz,Hilke Vorwerk,Andrea Hille,Christoph Matthias,Clemens F. Hess,Hans Christiansen
Journal of Cancer Research and Clinical Oncology.2009;135(7)961
[DOI]
7In regards to Barkati et al. (Int J Radiat Oncol Biol Phys 2010;76:410–416)
Hans Christiansen,Ralph M.W. Rödel,Christoph Matthias,Clemens F. Hess,Hendrik A. Wolff
International Journal of Radiation Oncology*Biology*Physics.2010;78(2)639
[DOI]
8THE COMPARISON BETWEEN WEEKLY BLEOMYCIN WITH THREE-WEEKLY CISPLATIN AND 5-FU DELIVERED CONCURRENTLY WITH RADIOTHERAPY IN HEAD AND NECK CANCER
Balasankar R,Nehru B,Syed Fayaz Ahmed
Journal of Evolution of Medical and Dental Sciences.2017;6(22)1772
[DOI]
9The comparison between weekly and three-weekly cisplatin delivered concurrently with radiotherapy for patients with postoperative high-risk squamous cell carcinoma of the oral cavity
Din-Li Tsan,Chien-Yu Lin,Chung-Jan Kang,Shiang-Fu Huang,Kang-Hsing Fan,Chun-Ta Liao,I-How Chen,Li-Yu Lee,Hung-Ming Wang,Joseph Tung-Chieh Chang
Radiation Oncology.2012;7(1)215
[DOI]
10Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial
Vanita Noronha,Amit Joshi,Vijay Maruti Patil,Jaiprakash Agarwal,Sarbani Ghosh-Laskar,Ashwini Budrukkar,Vedang Murthy,Tejpal Gupta,Anil K. D’Cruz,Shripad Banavali,Prathamesh S. Pai,Pankaj Chaturvedi,Devendra Chaukar,Nikhil Pande,Arun Chandrasekharan,Vikas Talreja,Dilip Harindran Vallathol,Vijayalakshmi Mathrudev,Aparna Manjrekar,Kamesh Maske,Arati Sanjay Bhelekar,Kavita Nawale,Sadhana Kannan,Vikram Gota,Atanu Bhattacharjee,Shubhada Kane,Shashikant L. Juvekar,Kumar Prabhash
Journal of Clinical Oncology.2018;36(11)1064
[DOI]
11Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic review
Primož Strojan,Jan B. Vermorken,Jonathan J. Beitler,Nabil F. Saba,Missak Haigentz,Paolo Bossi,Francis P. Worden,Johannes A. Langendijk,Avraham Eisbruch,William M. Mendenhall,Anne W. M. Lee,Louis B. Harrison,Carol R. Bradford,Robert Smee,Carl E. Silver,Alessandra Rinaldo,Alfio Ferlito,David W. Eisele
Head & Neck.2016;38(S1)E2151
[DOI]
12Weekly Cisplatin-Based Concurrent Chemoradiotherapy for Treatment of Locally Advanced Head and Neck Cancer: a Single Institution Study
Saptarshi Ghosh,Pamidimukkala Brahmananda Rao,P Ravindra Kumar,Surendra Manam
Asian Pacific Journal of Cancer Prevention.2015;16(16)7309
[DOI]
13The comparison of acute toxicity in 2 treatment courses
Jacek Mackiewicz,Agnieszka Rybarczyk-Kasiuchnicz,Izabela Lasinska,Malgorzata Mazur-Roszak,Daria Swiniuch,Michal Michalak,Joanna Kazmierska,Adam Studniarek,Lukasz Krokowicz,Tomasz Bajon
Medicine.2017;96(51)e9151
[DOI]
14Comparing high-dose cisplatin with cisplatin-based combination chemotherapy in definitive concurrent chemoradiation setting for locally advanced head and neck squamous cell carcinoma (LAHNSCC)
Muhammad Furqan,Travis P. Snyders,Mohammed U. Saqlain,Sarah L. Mott,Douglas Laux,Anthony Snow,Carryn M. Anderson,John M. Watkins,Gerald H. Clamon
Cancer Medicine.2019;96(51)e9151
[DOI]
15Concurrent Chemoradiation with Weekly Cisplatin for the Treatment of Head and Neck Cancers: an Institutional Study on Acute Toxicity and Response to Treatment
Saptarshi Ghosh,Pamidimukkala Brahmananda Rao,P Ravindra Kumar,Surendra Manam
Asian Pacific Journal of Cancer Prevention.2015;16(16)7331
[DOI]
163-weekly or weekly cisplatin concurrently with radiotherapy for patients with squamous cell carcinoma of the head and neck – a multicentre, retrospective analysis
Seth Helfenstein,Oliver Riesterer,Urs R. Meier,Alexandros Papachristofilou,Benjamin Kasenda,Miklos Pless,Sacha I. Rothschild
Radiation Oncology.2019;14(1)7331
[DOI]
17The comparison of weekly and three-weekly cisplatin chemotherapy concurrent with radiotherapy in patients with previously untreated inoperable non-metastatic squamous cell carcinoma of the head and neck
Kazim Uygun,Ahmet Bilici,Hakan Karagol,Murat Caloglu,Irfan Cicin,Gorkem Aksu,Merdan Fayda,Sernaz Uzunoglu
Cancer Chemotherapy and Pharmacology.2009;64(3)601
[DOI]
18Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: A cost-effectiveness analysis
Weiting Liao,Jiaxing Huang,Qiuji Wu,Guiqi Zhu,Xinyuan Wang,Feng Wen,Pengfei Zhang,Nan Zhang,Qiu Li
Oral Oncology.2019;93(3)15
[DOI]
19Current State-of-the-Art for Concurrent Chemoradiation
Jacques Bernier
Seminars in Radiation Oncology.2009;19(1)3
[DOI]
20The evidence on effectiveness of weeklyvstriweekly cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell carcinoma (HNSCC): a systematic review and meta-analysis
JC Kennetth Jacinto,Jayson Co,Michael Benedict Mejia,Eugenio Emmanuel Regala
The British Journal of Radiology.2017;90(1079)20170442
[DOI]
21Management of locally advanced HPV-related oropharyngeal squamous cell carcinoma: where are we?
Stuart E. Samuels,Avraham Eisbruch,Jonathan J. Beitler,June Corry,Carol R. Bradford,Nabil F. Saba,Michiel W. M. van den Brekel,Robert Smee,Primož Strojan,Carlos Suárez,William M. Mendenhall,Robert P. Takes,Juan P. Rodrigo,Missak Haigentz,Alexander D. Rapidis,Alessandra Rinaldo,Alfio Ferlito
European Archives of Oto-Rhino-Laryngology.2016;273(10)2877
[DOI]
22A meta-analysis of weekly cisplatin versus three weekly cisplatin chemotherapy plus concurrent radiotherapy (CRT) for advanced head and neck cancer (HNC)
Jian Guan,Yue Zhang,Qinyang Li,Yaowei Zhang,Lu Li,Min Chen,Nanjie Xiao,Longhua Chen
Oncotarget.2016;7(43)70185
[DOI]
23The in vitro and in vivo antitumor effects of Dracaena cinnabari resin extract on oral cancer
Nashwan Abdullah Al-Afifi,Aied M. Alabsi,Gohar Shaghayegh,Anand Ramanathan,Rola Ali,May Alkoshab,Marina Mohd Bakri
Archives of Oral Biology.2019;104(43)77
[DOI]
24Conventional Radiotherapy with Concurrent Weekly Cisplatin in Locally Advanced Head and Neck Cancers of Squamous Cell Origin - a Single Institution Experience
Kislay Dimri,Awadhesh Kumar Pandey,Romeeta Trehan,Bhavana Rai,Anup Kumar
Asian Pacific Journal of Cancer Prevention.2013;14(11)6883
[DOI]
25Conventional Radiotherapy with Concurrent Weekly Cisplatin in Locally Advanced Head and Neck Cancers of Squamous Cell Origin - a Single Institution Experience
Sue S Yom,Joseph Wee
Asian Pacific Journal of Cancer Prevention.2014;14(11)230
[DOI]
26Investigation of p16 status, chemotherapy regimen, and other nutrition markers for predicting gastrostomy in patients with head and neck cancer
Teresa E. Brown,Kym Wittholz,Mandy Way,Merrilyn D. Banks,Brett G. M. Hughes,Charles Y. Lin,Lizbeth M. Kenny,Judith D. Bauer
Head & Neck.2017;39(5)868
[DOI]
27Treatment de-intensification strategies for head and neck cancer
Jacqueline R. Kelly,Zain A. Husain,Barbara Burtness
European Journal of Cancer.2016;68(5)125
[DOI]
28Randomized controlled study comparing simultaneous modulated accelerated radiotherapy versus simultaneous integrated boost intensity modulated radiotherapy in the treatment of locally advanced head and neck cancer
Sarthak Tandon,Munish Gairola,Parveen Ahlawat,Sheh Rawat,Archana Aggarwal,Kanika Sharma,Sandeep Tiwari,Ahmad M. Karimi,Vinayakumar Muttagi,Nishtha Sachdeva,Manindra Bhushan
Journal of the Egyptian National Cancer Institute.2018;30(3)107
[DOI]
29Treating Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck Unsuitable to Receive Cisplatin-Based Therapy
Sandro V. Porceddu,Florian Scotté,Matti Aapro,Satu Salmio,Ana Castro,Vincent Launay-Vacher,Lisa Licitra
Frontiers in Oncology.2020;9(3)107
[DOI]

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal